Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Zebrafish Larvae Model of Dilated Cardiomyopathy Induced by Terfenadine

  • Gu, Gyojeong (Department of Microbiology and Immunology, Institute of Endemic Disease, Seoul National University College of Medicine) ;
  • Na, Yirang (Department of Microbiology and Immunology, Institute of Endemic Disease, Seoul National University College of Medicine) ;
  • Chung, Hyewon (Department of Microbiology and Immunology, Institute of Endemic Disease, Seoul National University College of Medicine) ;
  • Seok, Seung Hyeok (Department of Microbiology and Immunology, Institute of Endemic Disease, Seoul National University College of Medicine) ;
  • Lee, Hae-Young (Department of Internal Medicine, Seoul National University College of Medicine)
  • Received : 2017.04.10
  • Accepted : 2017.07.27
  • Published : 2017.11.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: Dilated cardiomyopathy can be the end-stage of severe cardiac disorders and directly affects the cardiac muscle, inducing cardiomegaly and heart failure (HF). Although a wide variety of animal models are available to study dilated cardiomyopathy, there is no model to assess dilated cardiomyopathy with non-invasive, simple, and large screening methods. Materials and Methods: We developed a dilated cardiomyopathy model in zebrafish larvae using short duration terfenadine, a known cardiotoxic drug that induces ventricular size dilation. Fractional shortening of zebrafish hearts was calculated. Results: We treated zebrafish with 5 to $10{\mu}M$ terfenadine for 24 hours. In terfenadine-treated zebrafish, blood frequently pooled and clotted in the chamber, and circulation was remarkably reduced. Atria and ventricles were swollen, and fluid was deposited around the heart, mimicking edema. Cardiac contractility was significantly reduced, and ventricular area was significantly enlarged. Heart rate was markedly reduced even after terfenadine withdrawal. Acridine orange staining also showed that terfenadine increased cardiomyocyte apoptosis. A significant increase of natriuretic peptide B (NPPB) mRNA was found in terfenadine-treated zebrafish. A low dose of terfenadine ($5-10{\mu}M$) did not show mortality in short-term treatment (24 hours). However, moderate dose ($35-45{\mu}M$) terfenadine treatment reduced zebrafish survival within 1 hour. Conclusion: With advantages of rapid sample preparation procedure and transparent observation of the live heart, this model can potentially be applied to large-scale drug screening and toxicity assays for non-ischemic HF.

Keywords

Acknowledgement

Supported by : Korean Society of Cardiology

References

  1. Tang C, Xie D, Feng B. Zebrafish as a new model for phenotype-based screening of positive inotropic agents. Chem Biol Drug Des 2015;85:253-8. https://doi.org/10.1111/cbdd.12389
  2. Huang CC, Monte A, Cook JM, Kabir MS, Peterson KP. Zebrafish heart failure models for the evaluation of chemical probes and drugs. Assay Drug Dev Technol 2013;11:561-72. https://doi.org/10.1089/adt.2013.548
  3. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-200. https://doi.org/10.1093/eurheartj/ehw128
  4. Lee SE, Cho HJ, Lee HY, et al. A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry. Eur J Heart Fail 2014;16:700-8. https://doi.org/10.1002/ejhf.91
  5. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980;44:672-3. https://doi.org/10.1136/hrt.44.6.672
  6. Beltrami CA, Finato N, Rocco M, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994;89:151-63. https://doi.org/10.1161/01.CIR.89.1.151
  7. Du CK, Morimoto S, Nishii K, et al. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res 2007;101:185-94. https://doi.org/10.1161/CIRCRESAHA.106.146670
  8. Mahmoudabady M, Niazmand S, Shafei MN, McEntee K. Investigation of apoptosis in a canine model of chronic heart failure induced by tachycardia. Acta Physiol Hung 2013;100:435-44. https://doi.org/10.1556/APhysiol.100.2013.4.8
  9. Tanaka Y, Rahmutula D, Duggirala S, et al. Diffuse fibrosis leads to a decrease in unipolar voltage: validation in a swine model of premature ventricular contraction-induced cardiomyopathy. Heart Rhythm 2016;13:547-54. https://doi.org/10.1016/j.hrthm.2015.09.025
  10. Gava FN, Zacche E, Ortiz EM, et al. Doxorubicin induced dilated cardiomyopathy in a rabbit model: an update. Res Vet Sci 2013;94:115-21. https://doi.org/10.1016/j.rvsc.2012.07.027
  11. Robert J. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors. Cardiovasc Toxicol 2007;7:135-9. https://doi.org/10.1007/s12012-007-0022-4
  12. Teerlink JR, Pfeffer JM, Pfeffer MA. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res 1994;75:105-13. https://doi.org/10.1161/01.RES.75.1.105
  13. Shih YH, Zhang Y, Ding Y, et al. Cardiac transcriptome and dilated cardiomyopathy genes in zebrafish. Circ Cardiovasc Genet 2015;8:261-9. https://doi.org/10.1161/CIRCGENETICS.114.000702
  14. Bakkers J. Zebrafish as a model to study cardiac development and human cardiac disease. Cardiovasc Res 2011;91:279-88. https://doi.org/10.1093/cvr/cvr098
  15. Jung DW, Oh ES, Park SH, et al. A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening. Mol Biosyst 2012;8:1930-9. https://doi.org/10.1039/c2mb05501e
  16. Asnani A, Peterson RT. The zebrafish as a tool to identify novel therapies for human cardiovascular disease. Dis Model Mech 2014;7:763-7. https://doi.org/10.1242/dmm.016170
  17. Zunkler BJ, Kuhne S, Rustenbeck I, Ott T. Mechanism of terfenadine block of ATP-sensitive K(+) channels. Br J Pharmacol 2000;130:1571-4. https://doi.org/10.1038/sj.bjp.0703483
  18. Hove-Madsen L, Llach A, Molina CE, et al. The proarrhythmic antihistaminic drug terfenadine increases spontaneous calcium release in human atrial myocytes. Eur J Pharmacol 2006;553:215-21. https://doi.org/10.1016/j.ejphar.2006.09.023
  19. Fearnley CJ, Roderick HL, Bootman MD. Calcium signaling in cardiac myocytes. Cold Spring Harb Perspect Biol 2011;3:a004242.
  20. Huang CJ, Tu CT, Hsiao CD, Hsieh FJ, Tsai HJ. Germ-line transmission of a myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish. Dev Dyn 2003;228:30-40. https://doi.org/10.1002/dvdy.10356
  21. Paquet D, Bhat R, Sydow A, et al. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J Clin Invest 2009;119:1382-95. https://doi.org/10.1172/JCI37537
  22. Milan DJ, Peterson TA, Ruskin JN, Peterson RT, MacRae CA. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 2003;107:1355-8. https://doi.org/10.1161/01.CIR.0000061912.88753.87
  23. Kooij V, Venkatraman V, Tra J, et al. Sizing up models of heart failure: proteomics from flies to humans. Proteomics Clin Appl 2014;8:653-64. https://doi.org/10.1002/prca.201300123
  24. Tsang M. Zebrafish: a tool for chemical screens. Birth Defects Res C Embryo Today 2010;90:185-92. https://doi.org/10.1002/bdrc.20183
  25. Peterson RT, Link BA, Dowling JE, Schreiber SL. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci U S A 2000;97:12965-9. https://doi.org/10.1073/pnas.97.24.12965
  26. Schoenebeck JJ, Yelon D. Illuminating cardiac development: advances in imaging add new dimensions to the utility of zebrafish genetics. Semin Cell Dev Biol 2007;18:27-35. https://doi.org/10.1016/j.semcdb.2006.12.010
  27. Buhler A, Kustermann M, Bummer T, Rottbauer W, Sandri M, Just S. Atrogin-1 deficiency leads to myopathy and heart failure in zebrafish. Int J Mol Sci 2016;17:E187. https://doi.org/10.3390/ijms17020187
  28. Cui G, Chen H, Cui W, et al. FGF2 prevents sunitinib-induced cardiotoxicity in zebrafish and cardiomyoblast H9c2 cells. Cardiovasc Toxicol 2016;16:46-53. https://doi.org/10.1007/s12012-015-9315-1

Cited by

  1. A Zebrafish Heart Failure Model for Assessing Therapeutic Agents vol.15, pp.3, 2017, https://doi.org/10.1089/zeb.2017.1546
  2. Generation and Application of the Zebrafish heg1 Mutant as a Cardiovascular Disease Model vol.10, pp.11, 2017, https://doi.org/10.3390/biom10111542
  3. The effect of ginsenoside Rg5, isolated from black ginseng, on heart failure in zebrafish based on untargeted metabolomics vol.76, pp.None, 2017, https://doi.org/10.1016/j.jff.2020.104325
  4. Zebrafish Heart Failure Models vol.9, pp.None, 2021, https://doi.org/10.3389/fcell.2021.662583
  5. Cardioluminescence in Transgenic Zebrafish Larvae: A Calcium Imaging Tool to Study Drug Effects and Pathological Modeling vol.9, pp.10, 2017, https://doi.org/10.3390/biomedicines9101294
  6. Zebrafish Embryos and Larvae as Alternative Animal Models for Toxicity Testing vol.22, pp.24, 2021, https://doi.org/10.3390/ijms222413417